<DOC>
	<DOC>NCT00811473</DOC>
	<brief_summary>The purpose of this study is to determine if quetiapine fumarate extended-release (quetiapine XR or SEROQUELÂ® XR) 150 to 300 mg/day taken by itself is effective and safe in treating children or adolescents aged 10 to 17 with bipolar depression and if so, how it compares with placebo (a non-active tablet, like a sugar pill, that looks like quetiapine).</brief_summary>
	<brief_title>Pediatric Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision of informed consent by one or both parents or legal guardian and written assent by the patients before any study procedures are performed. The patient must have a documented clinical diagnosis for bipolar I or bipolar II disorder, and including current episode depressed. Patients are required to be in outpatient status at the enrollment and randomization visits and believed likely to remain an outpatient for the duration of the study. Patients must be able to swallow the study medication tablets. The patient must not have been diagnosed with Tourette's Disorder, ObsessiveCompulsive Disorder, acute Posttraumatic Stress Disorder, Panic Disorder, Autistic Disorder and/or Asperger's Disorder. Patient can not have a history of nonresponse to an adequate treatment to more than 2 antidepressants during the current episode. The patient must not have received electroconvulsive therapy (ECT) within 30 days before participating in the study. Patients who in your doctors judgement pose a current suicidal or homicidal risk.</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Bipolar Depression</keyword>
	<keyword>Depression</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Seroquel</keyword>
	<keyword>Bipolar Depression in Children and Adolescents</keyword>
</DOC>